First Header Logo Second Header Logo

Re: Evasion of Immunosurveillance by Genomic Alterations of PPAR?/RXRa in Bladder Cancer.

Atala A. Re: Evasion of Immunosurveillance by Genomic Alterations of PPAR?/RXRa in Bladder Cancer. J Urol. 2018 05; 199(5):1115-1116.

View in: PubMed